J8705 Topotecan oral
Also known as: Hycamtin, Oral topotecan
Topotecan administered orally; a topoisomerase I inhibitor chemotherapy drug used for ovarian cancer and small cell lung cancer.
In Plain Language
Cancer treatment pill; Chemotherapy medication
Clinical Context
Used for ovarian cancer, small cell lung cancer, and cervical cancer. Topoisomerase I inhibitor causing DNA strand breaks.
RVU Information
CPT J8705 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J8705?
CPT J8705 (Topotecan oral) is a J Codes (Drugs) code. Topotecan administered orally; a topoisomerase I inhibitor chemotherapy drug used for ovarian cancer and small cell lung cancer.
How is J8705 administered?
CPT J8705 is administered by a healthcare provider, typically via injection or infusion. Used for ovarian cancer, small cell lung cancer, and cervical cancer. Topoisomerase I inhibitor causing DNA strand breaks. It is used by Oncology, Gynecology, Pulmonology.
When is CPT J8705 used?
Used for ovarian cancer, small cell lung cancer, and cervical cancer. Topoisomerase I inhibitor causing DNA strand breaks.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.